{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:02:53Z","timestamp":1770433373536,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejca.2008.03.013","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T22:02:00Z","timestamp":1208469720000},"page":"1552-1558","source":"Crossref","is-referenced-by-count":84,"title":["The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastoma &gt;1 year of age on a high-risk treatment protocol: Results of the German Neuroblastoma Trial NB97"],"prefix":"10.1016","volume":"44","author":[{"given":"Matthias","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Schicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Berthold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2008.03.013_bib1","unstructured":"Kaatsch P, Spix C. Annual report 2005. German childhood cancer registry, Mainz; 2006. p. 56."},{"key":"10.1016\/j.ejca.2008.03.013_bib2","first-page":"49","article-title":"Spontaneous regression of neuroblastoma","volume":"44","author":"Evans","year":"1976","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ejca.2008.03.013_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.3.5926.301","article-title":"Neuroblastoma, its natural history and prognosis: a study of 487 cases","volume":"3","author":"Wilson","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.ejca.2008.03.013_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3835(03)00076-4","article-title":"Long-term results and risk profiles of patients in five consecutive trials (1979\u20131997) with stage 4 neuroblastoma over 1 year of age","volume":"197","author":"Berthold","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2008.03.013_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","article-title":"Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial","volume":"6","author":"Berthold","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2003.07.142","article-title":"Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy","volume":"21","author":"Kushner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib7","doi-asserted-by":"crossref","first-page":"BP45","DOI":"10.1007\/s00259-003-1138-9","article-title":"Guidelines for radioiodinated MIBG scintigraphy in children","volume":"30","author":"Oliver","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejca.2008.03.013_bib8","series-title":"Nuclear medicine in clinical diagnosis and treatment","first-page":"445","article-title":"MIBG therapy","author":"Hoefnagel","year":"2004"},{"key":"10.1016\/j.ejca.2008.03.013_bib9","doi-asserted-by":"crossref","unstructured":"Schmidt M, Simon T, Hero B, et al. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma ? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB 2004. Nuklearmedizin 2006; 45;145\u201351.","DOI":"10.1055\/s-0038-1625111"},{"key":"10.1016\/j.ejca.2008.03.013_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1625121","article-title":"Dosimetry for therapeutic treatment of neuroblastoma by 131 I-MIBG","volume":"45","author":"Sudbrock","year":"2006","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.ejca.2008.03.013_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0959-8049(94)00509-4","article-title":"A new 123 I-MIBG whole body scan scoring method -- application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma","volume":"31","author":"Ady","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2008.03.013_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<805::AID-CNCR29>3.0.CO;2-3","article-title":"Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system","volume":"77","author":"Suc","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2008.03.013_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00043426-199901000-00004","article-title":"Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma","volume":"21","author":"Perel","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-911X(200004)34:4<237::AID-MPO1>3.0.CO;2-J","article-title":"Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group","volume":"34","author":"Frappaz","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2003.09.122","article-title":"Correlation of early metastatic response by123 I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma","volume":"21","author":"Matthay","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib17","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1200\/JCO.2004.07.144","article-title":"Scintigraphic response by123 I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma","volume":"22","author":"Katzenstein","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pbc.20777","article-title":"Evaluation of semi-quantitative scoring systems for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma","volume":"47","author":"Messina","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2008.03.013_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00066-006-1498-8","article-title":"Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children >1 year with residual local disease","volume":"182","author":"Simon","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejca.2008.03.013_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","article-title":"Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumour Registry","volume":"16","author":"Ladenstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.mop.0000150631.60571.89","article-title":"The biologic basis for neuroblastoma heterogeneity and risk stratification","volume":"17","author":"Maris","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ejca.2008.03.013_bib22","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-05-2495","article-title":"Loss in chromosome 11q identifies tumours with increased risk for metastatic relapses in localized and 4S neuroblastoma","volume":"12","author":"Spitz","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2008.03.013_bib23","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1200\/JCO.2006.06.1879","article-title":"Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification","volume":"24","author":"Oberthuer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2008.03.013_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/1096-911X(20010101)36:1<220::AID-MPO1053>3.0.CO;2-6","article-title":"Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma","volume":"36","author":"Hero","year":"2001","journal-title":"Med Pediatr Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804908002463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804908002463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:17:46Z","timestamp":1557494266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804908002463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0959804908002463"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2008.03.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}